Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
The Journal of Endocrinology|December 10, 1998
Epidermal growth factor binding sites in human pituitary macroadenomasM L Jaffrain-Rea, E Petrangeli, C Lubrano, et al.The Journal of Endocrinology|November 1, 1996
Cellular receptors for sex steroids in human pituitary adenomasM L Jaffrain-Rea, E Petrangeli, F Ortolani, et al.The Journal of Endocrinology|November 9, 2004
Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cellsM Theodoropoulou, T Arzberger, Y Gruebler, et al.Endocrine-Related Cancer|July 18, 2002
A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomasM L Jaffrain-Rea, D Di Stefano, G Minniti, et al.Journal of Endocrinological Investigation|April 1, 2010
The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: Mutational hot-spot or founder effect?G Occhi, M L Jaffrain-Rea, G Trivellin, et al.Journal of Endocrinological Investigation|June 29, 2020
The prevalence of silent acromegaly in prolactinomas is very lowC Bona, N Prencipe, M L Jaffrain-Rea, et al.The Journal of Clinical Endocrinology and Metabolism|November 30, 2000
Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg)R Baldelli, A Colao, P Razzore, et al.Clinical Endocrinology|September 1, 1999
Comparison of six months therapy with octreotide versus lanreotide in acromegalic patients: a retrospective studyP Razzore, A Colao, R Baldelli, et al.Clinical Endocrinology|September 1, 1999
p16 (INK4a, MTS-1) gene polymorphism and methylation status in human pituitary tumoursM L Jaffrain-Rea, E Ferretti, E Toniato, et al.The Journal of Endocrinology|September 1, 2007
Differential expression of neurogenins and NeuroD1 in human pituitary tumoursA Fratticci, F A Grieco, C Spilioti, et al.Pageof 4